AUPH Q2 2019 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29,000+0.0% YoY

Gross Profit

-$11M-38355.2% margin

Operating Income

-$16M-56737.9% margin

Net Income

-$16M-54831.0% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

-3.3%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$151M

Total Liabilities

$25M

Stockholders' Equity

$126M

Cash & Equivalents

$131M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29,000	$29,000	+0.0%
Gross Profit	-$11M	-$10M	-6.2%
Operating Income	-$16M	-$14M	-14.7%
Net Income	-$16M	-$16M	-1.2%